Thiruselvam Viswanathan is a researcher in the Hitendra Chand Lab, where he studies protein structure-function relationships in human disease. His work utilizes structural biology to aid in the development of innovative drug discovery methods.
During his postdoctoral training at Florida International University, his work focused on the structure-function characterization of the antimony-binding protein (AntR) and its mechanism of detoxification. He also characterized the genes ArsR, ArsQ, and ArsM, which are responsible for arsenic-based antibiotic (AST) production.
Before joining FIU in 2022, Viswanathan was a postdoctoral fellow at the Cancer Prevention and Research Institute of Texas, where he studied protein complexes involved in pediatric cancer to support drug discovery and development efforts. He also solved the structure of the nsp16/10 complex from SARS-CoV-2.
Areas of Expertise
- Structural biology
- Drug Discovery
- Protein Biochemistry
Research Interests
- Structure-based drug discovery
- Artificial intelligence (AI) and machine learning (ML) integration in drug discovery
- Drug discovery for "undruggable" targets
See research publications and more on FIU Discovery.
Education
- Ph.D., Chemistry, Crystallography & Biophysics, University of Madras, India
- MS, Chemistry, Bharathidasan University, India
- BS, Chemistry, Bharathidasan University, India